Industry Insight

Major advances in areas such as genomics, proteomics, and transcriptomics combined with high throughput screening and informatics are leading to new and exciting understanding of the molecular basis of disease. These offer the potential for new drug discoveries for treatment of many life threatening and debilitating diseases such as Parkinson’s, Alzheimer’s, cancers, heart diseases, rheumatoid arthritis, and many more.

The translation of potential new drug discoveries into affordable, safe, and efficacious medicines and therapies presents a host of challenges that go beyond and above discovery, and require a talent pool of scientists and engineers with a strong and disciplined knowledge base at the interface between discovery and biomanufacturing.

Biopharmaceutical processing is the discipline that holistically combines all the components necessary to translate life science discoveries into commercial products. These components include:

  • Bioproduct and bioprocess research
  • Development and characterization
  • Biomanufacturing platform development
  • Bioprocess modeling and scale up/scale-down validation
  • Quality and regulatory compliance
  • Process transfer to biomanufacturing

Biopharmaceutical processing is a subject of high professional standing and its contributions to human healthcare and economic growth over the past four decades have been phenomenal.

The role that biopharmaceutical processing plays in the current COVID-19 pandemic is tremendous. Click here to view a therapeutic development tracker.


Growth in Employer Demand, 2010-14

"KGI is a small school that caters to students. Professors always have an open-door policy and are happy to discuss anything. The labs available to conduct experiments is extremely valuable because they are comparable to industry operation. The curriculum is the most important thing because having background knowledge immediately puts you ahead of the curve."
Brian Avina
KGI student
Master of Engineering in Biopharmaceutical Processing, '21